Urban Supreme System

Judging from the outside world's valuation of Changhua Pharmaceutical, the conditions Zheng Yan is now offering can be regarded as a premium acquisition.

With such conditions, it can even be said that the premium is almost double, which is why Zheng Yan is so confident and thinks that Su Zhe will definitely agree.

In fact, given the relationship between Zheng Yan and Su Zhe, although he wanted to acquire Changhua Pharmaceutical, he would not want to exchange shares for shares.

But there is no way now. This is the unanimous decision of the top management of Zheng Pharmaceutical Group. They all believe that Changhua Pharmaceutical can develop so quickly. It must be related to Su Zhe. It is because of him that Changhua Pharmaceutical came back to life. , including Zheng Yan, also thought so.

Without Su Zhe, Changhua Pharmaceutical may not have any advantages. Even if Zheng Pharmaceutical Group acquires Changhua Pharmaceutical, it is estimated that there will be no development prospects.

However, Changhua Pharmaceutical, which has great development potential, is something Zheng does not want to give up.

Therefore, the top management of the group wanted to use the method of stock-for-share exchange to merge Changhua Pharmaceutical into the Zheng Group, and then slowly assimilate Changhua Pharmaceutical.

After obtaining from Su Zhe the method for the rapid development of Changhua Pharmaceutical, we will then find a way to kick him out of the Zheng Group.

For these capitalists, they all believe that it is very easy to recover the shares owned by Su Zhe, so they have nothing to worry about.

Although Zheng Yan was very dissatisfied with Su Zhe and wanted to kill him quickly, he also knew that this plan would be in the greatest interest of Zheng Pharmaceutical Group.

Now Zheng's Pharmaceutical Group. It is very necessary for Changhua Pharmaceutical to join so that it can occupy a place in the pharmaceutical industry.

For a family like the Zheng family. Maximizing interests is the most important thing. When the other party has value, personal grudges can be put aside and ignored for the time being.

That's why Zheng Yan approached Su Zhe today and proposed a stock-for-share plan to him.

"No, I have no plans to sell my shares now."

Just when Zheng Yan was full of hope and thought Su Zhe would agree. Su Zhe refused directly.

Although this condition seemed very tempting, Su Zhe refused without hesitation. Because he never thought of selling Changhua Pharmaceutical's shares.

Hearing Su Zhe's answer, Zheng Yan smiled confidently,

It immediately froze on my face.

He believes that this condition is already very high, although Changhua Pharmaceutical has great development potential. There are many people who want to acquire shares of Changhua Pharmaceutical.

But even so, Zheng Yan is still confident that this condition is already the highest, and no one can exceed it.

But Zheng Yan never expected that Su Zhe would refuse very simply now, and without even taking a moment to think about it, he refused without even a trace of hesitation.

"Su Zhe, did you not hear the conditions I offered clearly? Or if you are dissatisfied with the conditions, then we can continue to discuss it." Zheng Yan is a little confused now and is not as polite to Su Zhe as before. Already called directly by name.

Because such a result was something Zheng Yan had never expected and was beyond his expectation.

He originally thought that Su Zhe was the best, and he was just striving to improve the conditions. He had already thought about how to deal with it, even as long as Su Zhe's demands were not excessive. He won't refuse.

Because as long as they get the shares of Changhua Pharmaceutical, the Zheng family will have the final say. Then it won't be Su Zhe's turn to make the decision.

And when Su Zhe has no use value, the Zheng family can still use some means to take back all these things and leave Su Zhe with nothing, so now even if Zheng Yan makes concessions to Su Zhe, he can agree.

But he didn't expect that Su Zhe would directly refuse. This was the result that Zheng Yan had least expected.

"No, I don't want to sell my shares." Su Zhe refused again.

Although Zheng Yan’s current offer is considered to be a premium acquisition in the eyes of the outside world.

Because based on the current valuation of Changhua Pharmaceutical by the outside world, Su Zhe's 60% stake is only worth three billion US dollars.

And now the conditions for Zheng Yan's prescription are already worth at least 5.8 billion US dollars. When Zheng develops the new drug, it may be worth more than 8 billion US dollars.

So calculated this way, this condition has far exceeded the value of 60% of Changhua Pharmaceutical's shares.

But this is only the outside world’s understanding of Changhua Pharmaceutical, which is not thorough enough. The real value of Changhua Pharmaceutical has not yet been seen, so it is only valued at US$5 billion, and this valuation only includes Changhua Pharmaceutical. It's just fixed assets, and drugs such as Thawling Ling are not included in it.

Because Changhua Pharmaceutical has never announced its revenue to the outside world, no outsider can know Changhua Pharmaceutical's profits.

With the existence of Su Zhe's cheating device, Changhua Pharmaceutical does not need to invest high R\u0026D expenses like other pharmaceutical companies. Therefore, Changhua Pharmaceutical's net profit is very considerable and unimaginable by outsiders.

Changhua Pharmaceutical's daily sales of each drug in the domestic market alone have reached more than five million tablets, and its daily net profit in the domestic market is more than 22 million.

The daily sales volume of each drug in foreign markets is about 6 million tablets. Because Changhua Pharmaceutical sells at higher prices in foreign markets, the net profit has increased several times. The net profit brought by foreign markets to Changhua Pharmaceutical The profit is more than 120 million per day.

Changhua Pharmaceutical's domestic and foreign markets have a daily net profit of more than 140 million.

That's 140 million a day, so Changhua Pharmaceutical's net profit in the next year will be more than 50 billion. Even if it is converted into US dollars, it will be more than 8.3 billion.

Changhua Pharmaceutical's net profit in the next year will be more than 8.3 billion U.S. dollars. If those evaluation agencies were informed, would they still be able to value Changhua Pharmaceutical at only 5 billion U.S. dollars?

This is obviously impossible. Even if the valuation is increased ten times, it is not excessive at all.

Considering the current development prospects of Changhua Pharmaceutical, as well as operating income and net profit, a valuation of at least 50 billion US dollars is reasonable. This is because the outside world has insufficient information, so it will give a valuation of 5 billion US dollars. The valuation in US dollars comes out.

In other words, the current value of Changhua Pharmaceutical is almost twice as high as the current market value of Zheng Pharmaceutical Group.

Calculated this way, 60% of Changhua Pharmaceutical's shares are worth at least 30 billion U.S. dollars. The current conditions offered by Zheng Yan, including shares and cash, are only 5.8 billion U.S. dollars. Such conditions , how is it different from the white wolf with empty gloves?

This is obviously a loss-making business. How could Su Zhe agree? Isn't this giving money to the Zheng Group in vain?

He saw the benefits in this very clearly, so he refused without hesitation. (To be continued)

... ()